News Centres

Influx Healthtech’s CEO and CMD, Dr. M.A. Chandniwala, recently represented the company at Alpha Ideas 2025, a prestigious investor meet held in Mumbai. The event is known for bringing together promising companies and connecting them with an exclusive audience of investors, analysts, and market participants. It provides a platform for…

Influx Healthtech Ltd, a leading CDMO (Contract Development and Manufacturing Organization) in the wellness and healthcare space, has received a significant repeat export order valued at approximately ₹1.2 crore from merchant exporter Octavius Pharma Pvt Ltd for the Sudanese market. This development marks yet another milestone in Influx’s growing global…

Influx Healthtech Ltd. is proud to announce that it has successfully completed the mandatory Good Manufacturing Practices (GMP) audit mandated by the Food Safety and Standards Authority of India (FSSAI), earning the prestigious A+ Exemplar grade. This certification highlights the company’s unwavering commitment to quality, safety, and regulatory compliance in…

Influx Healthtech Ltd, has achieved a milestone by receiving the FSSAI Form II approval for the use of Magnesium Glycinate in tablet, capsule, and liquid preparations. This approval, granted by the FSSAI Scientific Committee, reinforces Influx Healthtech’s commitment to innovation and regulatory compliance. Magnesium Glycinate is a highly bioavailable form…

In a significant milestone underscoring its commitment to global quality and ethical standards, Influx Healthtech Ltd. has successfully completed the NBC Universal Social Audit, a mandatory compliance audit for manufacturers producing goods associated with Disney’s licensed properties. This achievement not only highlights Influx Healthtech’s robust manufacturing practices but also reinforces…